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SUMMARY
Residual muscle weakness after general anaesthesia, assessed using handgrip strength, was audited in a teaching
hospital. The relationships between residual weakness, the use of muscle relaxants and patient characteristics were
examined. 
Handgrip strength was measured preoperatively, one hour postoperatively and one day postoperatively using a hand
dynamometer in 151 patients having general anaesthesia. Forty-nine patients received no muscle relaxant, 34 patients
received vecuronium and 68 received rocuronium. Patients were managed by their anaesthetist according to that
anaesthetist’s clinical choice. All patients who received muscle relaxants received neostigmine.
One hour postoperatively, there was a decline in handgrip strength of 16% for the no relaxant group, 24% for
vecuronium and 29% for rocuronium. The degree of weakness for the relaxant groups was unrelated to age (P=0.89)
but was strongly influenced by the patient’s sex. Almost all of the increased weakness with relaxants was found in the
female patients. The mean decline in handgrip strength in the male patients who received either vecuronium or
rocuronium was similar to that seen when relaxants had not been used (P=0.40). One hour postoperatively, female
patients showed a marked decrease in handgrip strength after both vecuronium and rocuronium (32% and 34%
respectively, combined P=0.01).
These results suggest that in usual clinical practice at our institution, female patients are more likely to have
residual weakness after muscle relaxants.
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Residual weakness after the use of muscle relax-
ants in association with general anaesthesia has been
shown to be quite common1,2. Residual muscle weak-
ness after pancuronium has been demonstrated one
hour postoperatively. There is little information
about the impact of vecuronium and rocuronium on
muscle power of patients in the postoperative period. 
MATERIALS AND METHODS
The audit was conducted after obtaining the
approval of the Royal Adelaide Hospital Ethics Com-
mittee. We examined muscle weakness (the differ-
ence between handgrip strength preoperatively and
postoperatively) in the patients audited. All patients
had general anaesthesia, and the results were
grouped based on whether the patient received no
muscle relaxant, rocuronium or vecuronium. 
One hundred and seventy-eight patients who
attended as elective day-of-surgery admissions
(planned for overnight hospital stay) were audited.
They all gave verbal consent to participate in the
audit after being given an explanatory sheet. 
Exclusion criteria were: not having general anaes-
thesia; not understanding English; not being able to
follow instructions; having impaired handgrip pre-
operatively (e.g. due to diseases such as rheumatoid
arthritis); and having surgery which might impair
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postoperative handgrip strength (e.g. breast or upper
limb surgery). Only those patients who received
either no relaxant or either vecuronium or rocu-
ronium were analysed as these three groups repre-
sented over 95% of the patients studied. All patients
who received a relaxant also received reversal with
neostigmine. There was no communication with the
anaesthetist about what anaesthetic drugs or muscle
relaxants were to be given and no information on
patient results were passed back to the anaesthetist.
The assessment of muscle weakness was done using
the My-Gripper™ (Japan) dynamometer which has
been shown to be a sensitive measure of residual
muscle weakness1. Handgrip force was assessed pre-
operatively in the day-of-surgery admission lounge,
one hour postoperatively in the postoperative re-
covery ward and 24 hours postoperatively when the
patient was in the surgical ward. The handgrip force
at each stage was measured as the mean of three
maximum squeezes of the “My-Gripper” dynamo-
meter with the dominant hand.
Statistical analysis was performed using a t-test
(paired or unpaired), or ANOVA with two sides.
RESULTS
A total of 178 patients were audited. Twenty-two
patients were excluded because they did not complete
the three assessments. Five patients who received
general anaesthesia with other relaxants were also
excluded from analysis. This analysis has been per-
formed on the remaining 151 patients. Forty-nine
patients did not receive relaxant, 34 patients received
vecuronium and 68 patients received rocuronium. 
Ninety-one patients had their ASA status recorded.
There was no significant difference in distribution of
ASA status between the groups (P=0.159).
At the one hour postoperative assessment, patients
who received general anaesthesia without relaxant
had a mean diminution of handgrip strength of
16.1%. Patients who received vecuronium had a mean
diminution of handgrip strength of 23.9% and those
who received rocuronium had a mean reduction of
29.3%. There was no significant trend to a greater or
lesser weakness with increasing age (Figure 1). This
was true for both males (r=0.11, P=0.51) and
females (r=0.02, P=0.86).
There was a striking difference in decline in hand-
257MUSCLE WEAKNESS AFTER MUSCLE RELAXANTS
Anaesthesia and Intensive Care, Vol. 32, No. 2, April 2004
FIGURE 1: Plot of age against the decrease in muscle power with relaxants for each patient. Overall there is no trend with age. The male
patients are designated by a solid dot and the female patients are designated by an open dot. It can be seen that there is a tendency for
females to have a greater decrease in muscle power, but this is not related to age for either group.
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grip strength in relation to muscle relaxant exposure
between the sexes (Table 1). The mean (SD) decline
in handgrip strength of the male and female patients
who did not receive relaxant was similar (–13.87±
14.49 and –18.59±18.70 respectively, P=0.33).
Female patients who received muscle relaxants had a
greater decline in handgrip strength with both
vecuronium (P=0.04) and rocuronium (P=0.01) than
female patients who received no relaxant. In contrast,
male patients who had relaxants had no greater
decline in handgrip strength than those who did not
have relaxants (P=0.52, ANOVA). 
Handgrip strength had largely recovered in all
groups by the 24 hour measurement. Clinically
insignificant decreases in handgrip strength at the
twenty-four hour measurement compared to the pre-
operative measurement were noted in all groups.
These differences were not statistically significant in
those who received no muscle relaxant (P=0.746),
nor in men who had received muscle relaxants 
(P= 0.582) but statistically significant (P=0.0002) in
women who had received muscle relaxants.
Male and female patients who received relaxant
had similar absolute doses. For vecuronium, males
received a mean dose of 9.18 mg (SD 3.09, N=15)
which was similar to the dose given to females, mean
8.46 mg (SD 3.45, N=16), P=0.55. For rocuronium,
males received a mean dose of 53.6 mg (SD 19.3, 
N=18) which was similar to the dose given to females,
mean 50.2 mg (SD 11.0, N=41), P=0.39. In addition,
the duration of anaesthesia was similar for both sexes.
With vecuronium, males had a mean duration of
anaesthesia of 110 minutes (SD 47.9, n=15) and
females a mean duration of 120 minutes (SD 36.4,
n=16) P=0.52. For rocuronium, males had a mean
duration of anaesthesia of 85.8 minutes (SD 43.4,
n=18) and females a mean duration of 86.8 minutes
(SD 36.0, n=41) P=0.93. Thus, although the audit
did not control the dose of relaxant or the duration of
anaesthesia, these appeared to be similar in both the
male and the female groups for each relaxant.
DISCUSSION
Postoperative muscle weakness can be a cause of
serious morbidity and the development of compli-
cations during the postoperative period. In some
patients, such as those with inadequate respiratory
reserve, full recovery of respiratory muscle strength 
is essential. Whether the degree of weakness found
here is of clinical importance in most patients is
unclear.
In this audit, general anaesthesia alone resulted in
a slight flexor forearm muscle weakness postopera-
tively. The use of vecuronium or rocuronium resulted
in significantly greater muscle weakness in female
patients one hour postoperatively compared with
females who had not received relaxants. Male
patients who received muscle relaxants had a decline
in handgrip strength similar to males who did not
receive relaxants. The explanation for these observa-
tions is unclear. Female patients received similar
doses of relaxant compared to males, but, given the
likely smaller lean body mass in females, this could
represent a relative overdose of relaxant.
The significant declines in handgrip strength noted
at one hour postoperatively had largely recovered in
all groups at the 24 hour measurement compared
with the preoperative measurement. There was a
statistically significant weakness still present at 24
hours in female patients who had received relaxants
but the small absolute value of this decline compared
to preoperative measurements seemed likely to be
clinically insignificant.
Sex differences for some drug effects are well
recognised, such as the female susceptibility to post-
operative nausea and vomiting being two to three
times greater than in males3 and a tendency for
females to have more rapid awakening from general
anaesthesia4. With relaxants, work by Xue and co-
workers has suggested a sex difference in the effect of
muscle relaxants5. They found that females were
approximately 30% more sensitive than males to
rocuronium by train-of-four testing during anaes-
thesia. They also found that the neuromuscular block
was significantly longer in males than females so that
possibly the two effects, susceptibility and duration 
of action may nullify each other giving a similar post-
operative recovery. They did recommend a reduced
dose of relaxant in females. Semple and coworkers
also compared male and female sensitivity to vecu-
ronium by train-of-four electromyography during
anaesthesia6. They found females more sensitive,
requiring 22% less drug on a per kilogram basis to
achieve the same degree of block. We are not aware
of any previous work looking at muscle power during
recovery that has identified a sex difference. Bailland
et al investigated residual block after vecuronium
TABLE 1
Percentage change in handgrip at one hour
Relaxant Male Female
Mean Standard Number Mean Standard Number
Deviation Deviation
None –13.87 14.49 26 –18.59 18.71 23
Vecuronium –14.73 19.55 17 –32.73 23.32 17
Rocuronium –19.60 21.37 23 –34.19 25.16 45
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without reversal in 568 patients. They found that
older patients were more susceptible but did not find
any differences between the sexes7.
The major finding in this audit is that female
patients who have received a muscle relaxant in con-
junction with a general anaesthetic have a substan-
tially greater risk of muscle weakness one hour after
the procedure. Thus extra care is appropriate with
female patients requiring muscle relaxants with
general anaesthesia. From these data, there is a case
for minimizing the dose of relaxant in females, per-
haps by titration with neuromuscular monitoring, to
reduce their greater risk of postoperative weakness.
Certainly close monitoring of muscle power is war-
ranted during recovery in female patients who have
been given relaxant anaesthesia.
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